{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:45:19Z","timestamp":1780393519792,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cgh.2017.03.021","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T15:02:27Z","timestamp":1490281347000},"page":"1162-1172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Michael F.","family":"Vaezi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Pandolfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.03.021_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2004.051821","article-title":"Epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"54","author":"Dent","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib2","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib3","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s40265-013-0101-8","article-title":"Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment","volume":"73","author":"Hom","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2017.03.021_bib4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.295.13.1566","article-title":"Can the clinical history distinguish between organic and functional dyspepsia?","volume":"295","author":"Moayyedi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2017.03.021_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0140-6736(90)90287-F","article-title":"Symptoms in gastro-oesophageal reflux disease","volume":"335","author":"Klauser","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2017.03.021_bib6","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1111\/j.1572-0241.1999.01502.x","article-title":"The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease","volume":"94","author":"Moayyedi","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2004.01897.x","article-title":"Systemic review: the prevalence and clinical course of functional dyspepsia","volume":"19","author":"El-Serag","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5056\/jnm.2010.16.2.148","article-title":"Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria","volume":"16","author":"Noh","year":"2010","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2017.03.021_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00004836-200605000-00007","article-title":"The long-term natural history of gastroesophageal reflux disease","volume":"40","author":"Sontag","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","article-title":"Symptomatic reflux disease: the present, the past and the future","volume":"63","author":"Boeckxstaens","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1572-0241.1999.1123_a.x","article-title":"Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology","volume":"94","author":"DeVault","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2008.08.044","article-title":"American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000016930","article-title":"Empirical trials in treatment of gastroesophageal reflux disease","volume":"18","author":"Fass","year":"2000","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2017.03.021_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2036.2011.04904.x","article-title":"Systematic review: the treatment of noncardiac chest pain","volume":"35","author":"Hershcovici","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib16","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/ajg.2014.237","article-title":"Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales","volume":"109","author":"Spiegel","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ajg.2011.146","article-title":"Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease","volume":"106","author":"Kahrilas","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cgh.2012.01.022","article-title":"Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease","volume":"10","author":"Kahrilas","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.03.021_bib19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1053\/gast.2000.20191","article-title":"Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations","volume":"119","author":"van Herwaarden","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib20","first-page":"454","article-title":"Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease","volume":"21","author":"Tack","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/dote.12219","article-title":"Role of a health psychologist in the management of functional esophageal complaints","volume":"28","author":"Riehl","year":"2015","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.cgh.2017.03.021_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2016.02.012","article-title":"Functional esophageal disorders","volume":"150","author":"Aziz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cgh.2012.09.006","article-title":"Management of belching, hiccups, and aerophagia","volume":"11","author":"Bredenoord","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.03.021_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2982.2009.01371.x","article-title":"Speech therapy in patients with excessive supragastric belching: a pilot study","volume":"22","author":"Hemmink","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2017.03.021_bib26","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/j.1572-0241.2006.00844.x","article-title":"Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials","volume":"101","author":"Qadeer","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-140-7-200404060-00011","article-title":"Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics","volume":"140","author":"Numans","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2017.03.021_bib28","first-page":"1181","article-title":"Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease","volume":"91","author":"Johnston","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2214\/ajr.162.3.8109509","article-title":"Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring","volume":"162","author":"Thompson","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2017.03.021_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-97-1-93","article-title":"Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy","volume":"97","author":"Richter","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2017.03.021_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/nmo.12457","article-title":"The diagnosis of gastro-esophageal reflux disease cannot be made with barium esophagograms","volume":"27","author":"Saleh","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2017.03.021_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2036.2011.04742.x","article-title":"Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease","volume":"34","author":"Savarino","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3109\/00365528709011148","article-title":"Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease","volume":"22","author":"Johnsson","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib35","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.cgh.2006.09.013","article-title":"Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials","volume":"4","author":"Gralnek","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.03.021_bib36","first-page":"48","article-title":"Inter- and intra-observer variability of the Los Angeles classification: a reassessment","volume":"10","author":"Nasseri-Moghaddam","year":"2007","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.cgh.2017.03.021_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jamcollsurg.2013.05.023","article-title":"Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel","volume":"217","author":"Jobe","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.cgh.2017.03.021_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1005449302408","article-title":"Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy","volume":"45","author":"Nandurkar","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2017.03.021_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11894-008-0048-1","article-title":"The value of esophageal histology in the diagnosis of gastroesophageal reflux disease in patients with heartburn and normal endoscopy","volume":"10","author":"Tytgat","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2017.03.021_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00535-012-0672-2","article-title":"Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn","volume":"48","author":"Savarino","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib41","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1097\/01.mlg.0000184325.44968.b1","article-title":"Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope)","volume":"115","author":"Milstein","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.cgh.2017.03.021_bib42","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00005537-200206000-00016","article-title":"The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease","volume":"112","author":"Branski","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1016\/j.cgh.2017.03.021_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2016.11.035","article-title":"The edematous and erythematous airway does not denote pathologic gastroesophageal reflux","volume":"183","author":"Rosen","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cgh.2017.03.021_bib44","first-page":"325","article-title":"Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux","volume":"62","author":"Johnson","year":"1974","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.gie.2008.09.022","article-title":"Esophageal-reflux monitoring","volume":"69","author":"Pandolfino","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2017.03.021_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1091-255X(99)80071-7","article-title":"Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication","volume":"3","author":"Campos","year":"1999","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.cgh.2017.03.021_bib47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjsurg.2004.01.010","article-title":"Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results","volume":"187","author":"Khajanchee","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.cgh.2017.03.021_bib48","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/gut.2005.064691","article-title":"Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different?","volume":"54","author":"Pandolfino","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib49","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/ajg.2016.145","article-title":"Oropharyngeal pH testing does not predict response to proton pump inhibitor therapy in patients with laryngeal symptoms","volume":"111","author":"Yadlapati","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib50","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gut.2003.033290","article-title":"Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux","volume":"53","author":"Sifrim","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ajg.2008.23","article-title":"Non-acid reflux: detection by multichannel intraluminal impedance and pH, clinical significance and management","volume":"104","author":"Vela","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2036.2003.01394.x","article-title":"Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH","volume":"17","author":"Vela","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib53","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10620-010-1381-4","article-title":"Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn\/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring","volume":"56","author":"Frazzoni","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2017.03.021_bib54","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s11605-008-0583-y","article-title":"Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring","volume":"12","author":"del Genio","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.cgh.2017.03.021_bib55","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1007\/s00464-013-2861-3","article-title":"Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication","volume":"27","author":"Frazzoni","year":"2013","journal-title":"Surg Endosc"},{"key":"10.1016\/j.cgh.2017.03.021_bib56","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ajg.2014.63","article-title":"Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters","volume":"109","author":"Patel","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib57","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/lary.21897","article-title":"Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux","volume":"121","author":"Francis","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.cgh.2017.03.021_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cgh.2015.06.026","article-title":"Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease","volume":"14","author":"Frazzoni","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.03.021_bib59","first-page":"358","article-title":"The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring","volume":"83","author":"Wiener","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib60","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0016-5085(94)90815-X","article-title":"The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data","volume":"107","author":"Weusten","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1572-0241.2006.00555.x","article-title":"Increasing yield also increases false positives and best serves to exclude GERD","volume":"101","author":"Connor","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib62","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/gut.2004.054981","article-title":"Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole","volume":"54","author":"Taghavi","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib63","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2011.07.009","article-title":"Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease","volume":"9","author":"Slaughter","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2017.03.021_bib64","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00004836-199000000-00006","article-title":"Cimetidine 800 mg twice daily for healing erosions and ulcers in gastroesophageal reflux disease","volume":"12","author":"Palmer","year":"1990","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib65","first-page":"28","article-title":"Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis","volume":"22","author":"Pace","year":"1990","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib66","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib67","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0016-5085(94)90749-8","article-title":"Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis [see comments]","volume":"106","author":"Marks","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib68","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1365-2036.1999.00656.x","article-title":"Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group","volume":"13","author":"Jansen","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1572-0241.2002.05532.x","article-title":"Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis","volume":"97","author":"Castell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib70","first-page":"780","article-title":"Value of physiologic assessment of foregut symptoms in a surgical practice","volume":"114","author":"Costantini","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.cgh.2017.03.021_bib71","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.32.8.845","article-title":"Natural history of gastro-oesophageal reflux disease without oesophagitis","volume":"32","author":"Pace","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/gast.2002.34748","article-title":"Prevalence of Barrett's esophagus in asymptomatic individuals","volume":"123","author":"Gerson","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00365529950172952","article-title":"Gastroesophageal reflux in healthy subjects. Significance of endoscopic findings, histology, age, and sex","volume":"34","author":"Stal","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib74","first-page":"933","article-title":"Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?","volume":"63","author":"Tefera","year":"1997","journal-title":"Am Surg"},{"key":"10.1016\/j.cgh.2017.03.021_bib75","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","article-title":"Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies","volume":"32","author":"El-Serag","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib76","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1046\/j.1365-2036.2000.00882.x","volume":"14","author":"Fass","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1155\/2012\/235476","article-title":"Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review","volume":"26","author":"van Zanten","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib78","first-page":"3","article-title":"Evaluation of the GERD Impact Scale, an international, validated patient questionnaire, in daily practice. Results of the ALEGRIA study","volume":"72","author":"Louis","year":"2009","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.cgh.2017.03.021_bib79","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1572-0241.2001.03451.x","article-title":"Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease","volume":"96","author":"Shaw","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib80","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.03.021_bib81","doi-asserted-by":"crossref","first-page":"C108","DOI":"10.12968\/hmed.2014.75.Sup7.C108","article-title":"The dangers of proton pump inhibitor therapy","volume":"75","author":"Owen","year":"2014","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.cgh.2017.03.021_bib82","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/gutjnl-2012-302737","article-title":"Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial","volume":"62","author":"Shaheen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.03.021_bib83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/apt.13115","article-title":"Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy","volume":"41","author":"Shaheen","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib84","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ajg.2011.121","article-title":"Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study","volume":"106","author":"Vakil","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib85","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1365-2036.2010.04283.x","article-title":"Effect of lesogaberan, a novel GABA(B)-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects","volume":"31","author":"Boeckxstaens","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.03.021_bib86","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2010.02.015","article-title":"The novel, peripherally restricted GABAB receptor agonist lesogaberan (AZD3355) inhibits acid reflux and reduces esophageal acid exposure as measured with 24-h pHmetry in dogs","volume":"634","author":"Branden","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cgh.2017.03.021_bib87","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ajg.2009.718","article-title":"Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease","volume":"105","author":"Gerson","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.03.021_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.cgh.2017.03.021_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(14)62046-1","article-title":"Development and validation of PRISM: a patient reported outcome measure for GERD patients who are partial or non-responders to PPI therapy","volume":"146","author":"Fuller","year":"2014","journal-title":"Gastroenterology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651730321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651730321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:21:35Z","timestamp":1761542495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651730321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S154235651730321X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.03.021","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}